| MAGNESIUM ALUMINUM SILICATE | MAGNESIUM ALUMINUM SILICATE | 6M3P64V0NC | CONCENTRATE / ORAL | 410 mg/5ml | | Exact identifier — unii candidate 17 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRACAUDAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | FILM, SOLUBLE / BUCCAL | | 3 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SYRUP / ORAL | 71 mg/5ml | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / NASAL | 20 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRATUMOR | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRAVESICAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | GEL / VAGINAL | | 20 mg | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | EMULSION / ORAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | NA | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | | 14 mg | Exact identifier — unii candidate 6 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / IONTOPHORESIS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / OPHTHALMIC | 0.05 %w/v | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / INTRAVITREAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | PASTE / ORAL | | 48 mg | Exact identifier — unii candidate 19 equally ranked IID candidates |
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | | 10 mg | Exact identifier — unii candidate 6 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | | 1720 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | | 7 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | LOTION / TOPICAL | 0.2 %w/w | | Exact identifier — unii candidate 19 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / PERIODONTAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRASPINAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / SUBMUCOSAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | | 500 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRABURSAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | FILM, EXTENDED RELEASE / TRANSDERMAL | 0.85 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRA-ARTERIAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CREAM / TOPICAL | 0.25 %w/w | | Exact identifier — unii candidate 19 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / URETERAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRAVASCULAR | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | ELIXIR / ORAL | 5.02 mg/5ml | | Exact identifier — unii candidate 35 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CAPSULE / ORAL | 8.5 mg | | Exact identifier — unii candidate 35 equally ranked IID candidates |
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, COATED / ORAL | NA | | Exact identifier — unii candidate 19 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | | 34 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / EPIDURAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRATHECAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | | 750 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CONCENTRATE / ORAL | | 20 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| MAGNESIUM ALUMINUM SILICATE | MAGNESIUM ALUMINUM SILICATE | 6M3P64V0NC | PASTE, DENTIFRICE / DENTAL | 0.4 %w/w | | Exact identifier — unii candidate 17 equally ranked IID candidates |
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CONCENTRATE / ORAL | | 1 mg | Exact identifier — unii candidate 19 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION / INTRAVENOUS | | 864 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION / ORAL | | 320 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | DISC / TOPICAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | | 2000 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION/ DROPS / OPHTHALMIC | 0.47 %w/v | | Exact identifier — unii candidate 19 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | POWDER, FOR SUSPENSION / ENDOTRACHEAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SUSPENSION / ORAL | | 160 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / PARENTERAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| MAGNESIUM ALUMINUM SILICATE | MAGNESIUM ALUMINUM SILICATE | 6M3P64V0NC | POWDER, FOR SUSPENSION / ORAL | NA | | Exact identifier — unii candidate 17 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRALESIONAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRAPERITONEAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| ASCORBYL PALMITATE | ASCORBYL PALMITATE | QN83US2B0N | SYSTEM / TOPICAL | 0.04 mg | | Exact identifier — unii candidate 6 equally ranked IID candidates |
| ASCORBYL PALMITATE | ASCORBYL PALMITATE | QN83US2B0N | TABLET / ORAL | 7.14 mg | | Exact identifier — unii candidate 6 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE, DELAYED RELEASE / ORAL | 0.25 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SUSPENSION / ORAL | | 400 mg | Exact identifier — unii candidate 19 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE, COATED PELLETS / ORAL | 0.01 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |